Dermatology
News
Investigational Psoriasis Drug Reduces Vessel Inflammation
Major Finding: At 12 weeks there was a dose-related response in inflammation in the most-diseased vessels of patients with plaque psoriasis and...
News
Skin Biopsy Can't Always Tell SLE From Dermatomyositis
Conference Coverage
Oral Spironolactone Hailed for Acne in Women
Conference Coverage
Antibiotics Lead Outpatient Cutaneous Adverse Drug Events
Major Finding: Antibiotics caused the most cutaneous adverse drug events (23%), followed by cardiovascular agents (7%) and agents primarily...
News
Investigational Herpes Drug May Offer Alternative to Valacyclovir
Major Finding: Median healing times were 140 hours for placebo, 120 hours for ASP2151 100 mg, 106 hours for ASP2151 200 mg, 116 hours for ASP2151...
News
Bexarotene Confers No Survival Benefit for Mycosis Fungoides
Major Finding: The median survival time for patients with tumor stage mycosis fungoides who received oral bexarotene therapy was 3.3 years,...
News
Acrylates Named Contact Allergen of the Year
News
Study Results Support Ingenol Mebutate's AK Effectiveness
Major Finding: In patients with facial or scalp lesions, 42.2% who used ingenol mebutate gel achieved complete clearance at 2 months, compared...
News
Sunburns Still Common Despite Protective Efforts
Major Findings: In 2010, 51% of women and 49% of men reported having at least one sunburn in the past year.